Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer.

Thomas BoernerClarissa LamDerman BasaranYing L LiuRachel N GrishamWilliam P TewKara Long RocheOliver ZivanovicNadeem R Abu-Rustum Ginger J GardnerYukio SonodaDennis S ChiGerald SoffElizabeth L Jewell

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)

Therapeutic anticoagulation in this setting appeared safe, with a low risk of major bleeding complications. Furthermore, anticoagulation did not result in delay of chemotherapy or cytoreductive surgery.

Keyphrases

venous thromboembolism
neoadjuvant chemotherapy
locally advanced
atrial fibrillation
newly diagnosed
direct oral anticoagulants
lymph node
sentinel lymph node
minimally invasive
rectal cancer
squamous cell carcinoma
polycystic ovary syndrome
radiation therapy
risk factors